Publications by authors named "Walter Olson"

Claim this Profile
A
Antibody Responses to Melanoma Helper Peptide Vaccines May Enhance Antigen Opsonization Through Formation of Immune Complexes and are Modulated by Vaccine Adjuvants.
Emily G Ashkani, Anna M Dickinson, Walter C Olson, Justin J Taylor, Craig L Slingluff

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates.
Arabinda Mandal, Jagathpala Shetty, Christine A Tran, Walter C Olson, Mriganka Mandal

J Immunother Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine.
Christine A Tran, Kevin T Lynch, Max O Meneveau, Priya Katyal, Walter C Olson

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64).
Rick Daniel Vavolizza, Gina R Petroni, Ileana S Mauldin, Kimberly A Chianese-Bullock, Walter C Olson

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nano-enhanced vaccine for metastatic melanoma immunotherapy.
Katelyn E Salotto, Walter C Olson, Karlyn E Pollack, Anuradha Illendula, Elishama Michel

Cancer Drug Resist· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes.
Abhinav Jaiswal, Akanksha Verma, Ruth Dannenfelser, Marit Melssen, Itay Tirosh, Walter C Olson

Cancer Cell· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancer.
Kevin T Lynch, Gabriella C Squeo, William J Kane, Max O Meneveau, Gina Petroni, Walter C Olson

Int J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma.
Sapna P Patel, Gina R Petroni, Jason Roszik, Walter C Olson, Nolan A Wages

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.
Max O Meneveau, Gina R Petroni, Elise P Salerno, Kevin T Lynch, Mark Smolkin, Walter C Olson

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Craig L Slingluff, Hassane M Zarour, Hussein Abdul-Hassan Tawbi, John M Kirkwood, Michael A Postow, Walter C Olson

Oncoimmunology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, Nolan A Wages, Walter C Olson

J Immunother Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma.
Marit M Melssen, Walter Olson, Nolan A Wages, Brian J Capaldo, Ileana S Mauldin

Oncoimmunology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.
Kiley A Knapp, Eusebio S Pires, Sara J Adair, Arabinda Mandal, Anne M Mills, Walter C Olson

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.
Patrick M Dillon, Gina R Petroni, Mark E Smolkin, David R Brenin, Kimberly A Chianese-Bullock, Walter C Olson

J Immunother Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies.
Girja S Shukla, Walter C Olson, Stephanie C Pero, Yu-Jing Sun, Chelsea L Carman

J Transl Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
Ileana S Mauldin, Nolan A Wages, Anne M Stowman, Ena Wang, Mark E Smolkin, Walter C Olson

Cancer Immunol Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.
Ileana S Mauldin, Nolan A Wages, Anne M Stowman, Ena Wang, Walter C Olson

Cancer Immunol Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.
Craig L Slingluff, Gina R Petroni, Walter C Olson, Mark E Smolkin, Kimberly A Chianese-Bullock

Cancer Immunol Immunother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10.
Ileana S Mauldin, Ena Wang, Donna H Deacon, Walter C Olson, Yongde Bao

Int J Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.
Caroline M Reed, Nicole D Cresce, Ileana S Mauldin, Craig L Slingluff, Walter C Olson

Clin Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.
Yinin Hu, Gina R Petroni, Walter C Olson, Andrea Czarkowski, Mark E Smolkin

Cancer Immunol Immunother· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes.
Patrick M Dillon, Walter C Olson, Andrea Czarkowski, Gina R Petroni, Mark Smolkin

J Immunother Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins.
Elise P Salerno, Walter C Olson, Chantel McSkimming, Sofia Shea, Craig L Slingluff

Int J Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).
Craig L Slingluff, Sandra Lee, Fengmin Zhao, Kimberly A Chianese-Bullock, Walter C Olson

Clin Cancer Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide.
Elise P Salerno, Sofia M Shea, Walter C Olson, Gina R Petroni, Mark E Smolkin

Cancer Immunol Immunother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis